Stoke Therapeutics, Inc. (STOK)
32.40
+1.92
(+6.30%)
USD |
NASDAQ |
Feb 06, 16:00
32.37
-0.03
(-0.09%)
After-Hours: 20:00
Stoke Therapeutics SG&A Expense (TTM) : 58.79M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biogen, Inc. | 2.434B |
| Insmed, Inc. | 631.20M |
| Pfizer Inc. | 13.79B |
| Mirum Pharmaceuticals, Inc. | 239.73M |
| Moderna, Inc. | 1.061B |